BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12067837)

  • 1. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
    Nakahara I; Matsuhisa M; Shiba Y; Kuroda A; Nakatani Y; Hatazaki M; Kajimoto Y; Kubota M; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK; van de Werve G; Giacca A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-dependent control of hepatic glycogen stores in healthy humans.
    Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
    Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs.
    Chu CA; Galassetti P; Igawa K; Sindelar DK; Neal DW; Burish M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E291-301. PubMed ID: 12531743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
    Boden G; Chen X; Capulong E; Mozzoli M
    Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pioglitazone on the liver: role of adiponectin.
    Gastaldelli A; Miyazaki Y; Mahankali A; Berria R; Pettiti M; Buzzigoli E; Ferrannini E; DeFronzo RA
    Diabetes Care; 2006 Oct; 29(10):2275-81. PubMed ID: 17003306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
    Li L; Yang GY
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
    Wise S; Nielsen M; Rizza R
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
    Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Park E; Wong V; Guan X; Oprescu AI; Giacca A
    J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats.
    Yang G; Li L; Fang C; Zhang L; Li Q; Tang Y; Boden G
    Metabolism; 2005 Sep; 54(9):1142-6. PubMed ID: 16125524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.
    Vella A; Reed AS; Charkoudian N; Shah P; Basu R; Basu A; Joyner MJ; Rizza RA
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E25-30. PubMed ID: 12637258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.